PSA consensus recommendations and implications for practice
Dr. Sam Merriel presents PSA consensus recommendations and implications for practice.
Lived experience conversation
Meg Burgess, Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.
Remote consultations: experiences of UK patients with prostate cancer during the COVID-19 pandemic
The article highlights that UK prostate cancer patients preferred in-person consultations for key discussions but accepted remote consultations for routine follow-ups, suggesting a balanced approach with critical decisions made face-to-face.
Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
Prostate Cancer Essentials: Part 1 – Introduction to Prostate Cancer
A course providing an introduction to the prostate and prostate cancer covering all of the essential information for healthcare professionals who have taken on a role supporting people affected by cancer.
Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
The article presents a consensus statement on prostate cancer active surveillance best practices in the UK, highlighting practice variations and the need for improved patient information and support.
Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010
The article reveals that Black men in England face significantly higher lifetime risks of prostate cancer diagnosis and mortality compared to White and Asian men, with the highest diagnosis and death rates among Black men, while mortality rates post-diagnosis are similar across ethnic groups.
Considerations for transgender and gender diverse patients with prostate cancer
Stewarts O’Callagham, CEO at OUTpatients, Alison Berner, Academic Clinical Lecturer at the Barts Cancer Institute , and Lloyd Young, patient with lived experience, share their considerations on the LGBTQI+ prostate cancer patients.
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus
The report examines the optimal use of the PSA test for detecting prostate cancer in asymptomatic UK men, recommends proactive testing for those at higher risk, and suggests reviewing existing guidelines to improve screening practices.
GIRFT Urology: Towards better diagnosis and management of suspected prostate cancer
Supported by BAUS and BAUN, the practical guidance provides a checklist and detailed principles for delivering top-quality care across the entire patient pathway, including primary care, secondary care, ongoing monitoring, biopsies, and treatment choices.